Literature DB >> 15116798

Hypothyroidism during pregnancy.

Alejandro A Nava-Ocampo, Offie P Soldin, Gideon Koren.   

Abstract

QUESTION: I have a 27-year-old patient diagnosed with hypothyroidism in the 8th week of pregnancy. She received conflicting opinions regarding risk for her baby and wants to get more information. I also found conflicting information in the literature. How should I advise her? ANSWER: Pregnant patients with untreated hypothyroidism are at increased risk of obstetric complications. Adequate treatment with thyroid hormones greatly reduces the frequency of these complications. Observational studies suggest that children whose mothers had hypothyroxinemia in early pregnancy have lower IQs than matched controls. Another study has shown that even if levothyroxine therapy is started after the first trimester, there is an excellent chance children will have normal neuropsychologic development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15116798      PMCID: PMC2214589     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

1.  Maternal thyroid deficiency and pregnancy complications: implications for population screening.

Authors:  W C Allan; J E Haddow; G E Palomaki; J R Williams; M L Mitchell; R J Hermos; J D Faix; R Z Klein
Journal:  J Med Screen       Date:  2000       Impact factor: 2.136

2.  Effect of calcium carbonate on the absorption of levothyroxine.

Authors:  N Singh; P N Singh; J M Hershman
Journal:  JAMA       Date:  2000-06-07       Impact factor: 56.272

3.  Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.

Authors:  J E Haddow; G E Palomaki; W C Allan; J R Williams; G J Knight; J Gagnon; C E O'Heir; M L Mitchell; R J Hermos; S E Waisbren; J D Faix; R Z Klein
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny.

Authors:  Rosalía Lavado-Autric; Eva Ausó; José Victor García-Velasco; María del Carmen Arufe; Francisco Escobar del Rey; Pere Berbel; Gabriella Morreale de Escobar
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

5.  Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy.

Authors:  V J Pop; J L Kuijpens; A L van Baar; G Verkerk; M M van Son; J J de Vijlder; T Vulsma; W M Wiersinga; H A Drexhage; H L Vader
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

6.  The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant.

Authors:  Aleid G van Wassenaer; Maykel R Stulp; Fredoen Valianpour; Pieter Tamminga; Carrie Ris Stalpers; Janine S E de Randamie; Christien van Beusekom; Jan J M de Vijlder
Journal:  Clin Endocrinol (Oxf)       Date:  2002-05       Impact factor: 3.478

Review 7.  Transfer of drugs and other chemicals into human milk.

Authors: 
Journal:  Pediatrics       Date:  2001-09       Impact factor: 7.124

Review 8.  Thyroid autoimmunity and hypothyroidism before and during pregnancy.

Authors:  Kris Poppe; Daniel Glinoer
Journal:  Hum Reprod Update       Date:  2003 Mar-Apr       Impact factor: 15.610

9.  Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy.

Authors:  B Contempré; E Jauniaux; R Calvo; D Jurkovic; S Campbell; G M de Escobar
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

10.  Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?

Authors:  Inder J Chopra; Khansa Baber
Journal:  Metabolism       Date:  2003-01       Impact factor: 8.694

View more
  1 in total

Review 1.  Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2006-02       Impact factor: 3.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.